United States · FDA National Drug Code directory
Biktarvy
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-6247_a3c4a0eb-71e8-4b35-9706-240874b78ee0
- Product NDC
- 50090-6247
- Form
- TABLET
- Composition / generic term
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- Labeler
- A-S Medication Solutions
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180207
- Source listing expiry
- 20261231
Source-listed ingredients
- BICTEGRAVIR SODIUM — 50 mg/1
- EMTRICITABINE — 200 mg/1
- TENOFOVIR ALAFENAMIDE FUMARATE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE, PLASTIC (50090-6247-0) · 50090-6247-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →